Figure 6.
Joint predicted impact of demographic changes and vaccination on the future epidemiology of HZ (2010–2050). Predicted age-specific HZ incidence at different years under the baseline demographic scenario and a vaccination programme starting in 2010 with 90% coverage and 100% lifelong efficacy. The inset shows the total HZ incidence over time disaggregated by age group.